# Samson Pharmaceuticals, Inc – FDA Inspection, Apr 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/samson-pharmaceuticals-inc/c5ccd952-6c74-486d-a807-a72f44173f28
Source feed: FDA_Inspections

> FDA inspection 1314718 of Samson Pharmaceuticals, Inc, April 29, 2026. 8 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314718
- Company Name: Samson Pharmaceuticals, Inc
- Inspection Date: 2026-04-29
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 8

## Related Documents

- [FDA Inspection 1040504 - 2018-02-09](https://www.keypedia.com/records/fda_inspections/samson-pharmaceuticals-inc/2fcc35f4-af43-4fb7-9992-894610e7c1dc)
- FDA Inspection 988639 - 2016-03-25

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/luis-f-torres/0b42aa90-0fa3-407d-bc65-75e270c4dec1)
- [Issuing Officer](https://www.keypedia.com/people/luis-p-torres/995f71e1-b7b8-4c30-9d53-2127b01f8d47)
- [FDA Associated Person](https://www.keypedia.com/people/taichun-qin/62349336-96d6-4452-9c20-9084204b86bf)
- [FDA Associated Person](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)

Company: https://www.keypedia.com/companies/samson-pharmaceuticals-inc/4250f533-840c-44d3-a3e7-cc538c63ca03

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
